During the fourth quarter, Intuitive Surgical ISRG placed 493 systems, up 19% from 415 in the year-ago period. Total system placements were record-high in the past year. This includes 284 ...

Over the past decade, Intuitive Surgical (NASDAQ: ISRG) has proven to be a long-term winner in the healthcare sector. The stock is up more than 950% in that time frame, and more than 60% over the ...

Below is Validea's guru fundamental report for INTUITIVE SURGICAL, INC. (ISRG). Of the 22 guru strategies we follow, ISRG rates highest using our Multi-Factor Investor model based on the published ...

Intuitive Surgical, Inc. (ISRG) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term ...

Below is a chart showing SBUX's trailing twelve month trading history, with the $100 strike highlighted in orange: And Intuitive Surgical Inc (Symbol: ISRG) options are showing a volume of 7,587 ...

In recent trading, shares of Intuitive Surgical Inc (Symbol: ISRG) have crossed above the average analyst 12-month target price of $581.33, changing hands for $584.08/share. When a stock reaches ...

Regarding ISRG (NASDAQ:ISRG), we observe a call option sweep with bearish sentiment. It expires in 4 day(s) on January 31, 2025. Parties traded 200 contract(s) at a $590.00 strike. This particular ...

Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic-assisted surgery. Our technologies include the da Vinci ...

Wall Street analysts forecast that Intuitive Surgical, Inc. (ISRG) will report quarterly earnings of $1.76 per share in its upcoming release, pointing to a year-over-year increase of 10%.

The company reported revenue of $2.4 billion and adjusted earnings of $2.21 per share, compared to the consensus estimates of ...

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) had its price target upped by analysts at Bernstein Bank from $655.00 to ...

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) had its price objective lifted by investment analysts at Barclays from ...